Arrest of Senior Huawei Executive Steps Up U.S.-China Confrontation 
 

The arrest of a senior executive of networking-gear maker Huawei Technologies Co. intensifies the confrontation in the already divisive China-U.S. negotiations on trade, striking at Chinese President Xi Jinping's ambitions to make the country a tech superpower .

 
Lampert's Hedge Fund Makes Bid for Sears Stores and Assets 
 

Edward Lampert, the chairman and biggest creditor of Sears Holdings Corp., has made an offer to buy the retailer's stores and other assets out of bankruptcy court in a bid to keep control of the struggling chain.

 
Fiat Chrysler Appoints Auto Veteran to Lead North American Operations 
 

Fiat Chrysler Automobiles named a former executive at the auto supplier now called ZF TRW as its new chief of North American operations.

 
Lyft Sets Stage for Early 2019 IPO 
 

Lyft is going public, announcing that it has confidentially filed a draft registration statement with the Securities and Exchange Commission, a key step by the closely held company in selling shares to the public.

 
Walgreens, FedEx Launch Next-Day Prescription Home Delivery 
 

Walgreens Boots Alliance is launching a nationwide prescription home-delivery service as the drugstore chain works to stave off competition from Amazon.com and other rivals.

 
Barrick Gold Retreats From Digital Reinvention 
 

Barrick Gold is selling a research and development company it owns and is cutting staff hired to lead what executives had called a digital reinvention, championed by Executive Chairman John Thornton.

 
Cell Service in Japan Goes Down for Hours, Clouding Year's Biggest IPO 
 

SoftBank's Japanese mobile unit suffered an hourslong nationwide network breakdown, tarnishing the unit's planned $23 billion initial public offering later this month.

 
Congress to Drug Makers: Why Stock Buybacks Over Lowered Drug Prices? 
 

House Democrats say big pharmaceutical companies channeled tax savings to repurchasing shares instead of making some medicines more affordable.

 
Highly Anticipated Moderna Listing Is Seen As Test of New IPOs 
 

The IPO market faces a major year-end test, as Moderna attempts on Thursday to stage one of the biggest stock-market debuts for a biotechnology company at a time of heightened investor jitters.

 
Och-Ziff to Change Structure as Hedge Fund Looks to Future 
 

Och-Ziff Capital Management revealed sweeping strategic changes designed to distribute power among a wider range of shareholders and help ensure the largest U.S. publicly traded hedge fund remains on firm footing.

(END) Dow Jones Newswires

December 06, 2018 11:15 ET (16:15 GMT)